Skip to main content
. Author manuscript; available in PMC: 2010 Oct 15.
Published in final edited form as: Nature. 2010 Apr 15;464(7291):999–1005. doi: 10.1038/nature08989

Table 1.

Summary of point mutations and small indels identified in the primary tumor, brain metastasis, and xenograft.

Chr Start Allele Change Gene Amino Acid Change Mutant Allele Frequency Copy Number Enrichment FDR
N T M X T M X M X
1 26062702 G>A PAQR7 p.A72 0.17% 5.78% 34.55% 13.70% 2 2 2 9.00e-4 0.011
1 26646672 G>A DHDDS p.R159H 0.14% 21.12% 40.24% 88.29% 2 2 2 5.73e-5 2.46e-5
1 43684654 G>A KIAA0467 p.G2119R 0.13% 7.00% 40.02% 84.84% 2 2 2 0.001 5.98e-5
1 45068225 C>G PTCH2 p.W293S 0.02% 13.70% 36.03% 43.61% 2 2 2 0.085 0.381
1 152723308 delGCAACTTTTCATT SHE p.LPFKG476in_frame_delW 0.19% 19.28% 21.33% 7.69% 4.61 5.34 6.92 0.820 0.065
1 226395989 C>A GUK1 p.P11Q 0.01% 36.29% 33.12% 40.17% 3.66 3.96 4.64 0.374 0.365
1 242935580 A>T PPPDE1 p.T151S 0.12% 3.39% 48.57% 11.47% 3.45 3.71 4.38 0.012 0.063
2 24994872 G>A ADCY3 p.H163 0.06% 7.10% 37.49% 48.71% 3.17 3.24 3.78 0.007 0.029
2 56273320 delG CCDC85A p.E161fs 0.16% 1.71% 17.11% 28.78% 2.9 3.24 3.34 0.002 0.006
2 197349569 G>C GTF3C3 p.R474G 0.11% 29.42% 37.75% 11.08% 1.4 1.31 1.24 0.316 0.065
2 229835724 C>T PID1 p.S14 0.11% 8.95% 38.89% 66.13% 2 2 1.36 0.001 0.166
2 241641282 C>T SNED1 p.T708I 0.04% 0.32% 36.52% 2.30% 2 2 2 1.58e-4 0.719
3 10236363 G>T IRAK2 e8-1 0.38% 48.37% 52.69% 53.33% 2 2 2 0.156 0.762
3 139505123 G>A TXNDC6 p.R221W 0.29% 39.50% 58.62% 15.81% 2 2 2 0.039 0.012
3 150728323 A>C WWTR1 p.F299V 0.03% 6.87% 28.14% 9.53% 2 2 2 1.43e-4 0.020
4 40051165 C>A CHRNA9 p.D437E 0.10% 28.38% 36.82% 90.26% 2 2 2 0.073 9.67e-5
4 40134827 delG RBM47 p.I280fs 0.05% 8.62% 79.15% 79.74% 2 2 2 0.030 0.124
4 82232630 C>T PRKG2 p.R709 0.11% 6.99% 82.99% 91.51% 2 2 2 0.083 0.094
5 135422725 G>A TGFBI p.E576K 0.17% 89.09% 37.58% 18.45% 2 2 2 3.34e-6 3.23e-5
5 169466048 C>T FOXI1 p.S170F 0.15% 69.28% 78.33% 93.61% 2 2 2 0.473 0.009
7 100463999 G>C MUC17 p.S861T 1.69% 9.22% 1.46% 14.43% 2 2.76 4.04 0.073 0.816
7 128284099 C>T FLNC p.N2483 0.11% 0.17% 18.21% 0.16% 2.54 2.8 2.93 0.002 0.193
7 148400407 G>A ZNF786 p.F130 0.13% 13.61% 62.86% 81.04% 2.51 2.85 3.54 3.01e-4 3.23e-5
8 3232441 C>A CSMD1 p.A409S 0.04% 29.75% 54.22% 65.18% 2 2 2 0.355 0.141
8 8477326 C>T ENSG00000222487 NULL 0.11% 9.61% 28.43% 13.74% 2 2 2.67 0.120 0.787
9 5040714 T>C JAK2 p.I166T 0.09% 61.63% 21.93% 47.40% 2.83 2.67 2.84 0.246 0.999
9 107137789 G>A SLC44A1 p.A132T 0.08% 2.59% 76.14% 85.31% 2 1.29 1.19 1.43e-4 1.05e-4
10 14603968 C>T FAM107B p.R237Q 2.65% 13.53% 63.25% 97.88% 3.7 4.04 4.76 3.29e-6 8.54e-8
10 30789749 C>T MAP3K8 p.P461L 0.11% 13.33% 31.72% 77.47% 3.44 3.71 4.21 0.002 9.67e-5
10 79240899 G>A DLG5 p.D1474 0.07% 32.94% 76.10% 74.72% 2 2 2 6.12e-5 0.011
11 12496610 insATGGAG PARVA p.338in_frame_insDG 0.00% 1.41% 10.75% 10.58% 2 2 2 0.347 0.365
11 48128224 A>T PTPRJ p.K1017N 0.20% 1.25% 32.08% 57.23% 2 2 2.99 3.48e-4 2.20e-4
11 102687902 G>A DYNC2H1 p.R3867Q 0.06% 12.81% 25.78% 15.69% 2 2 2 0.002 0.023
12 31122692 T>G DDX11 p.V33G 0.02% 44.35% 40.39% 57.88% 1.49 1.37 1.24 0.316 0.386
13 76628331 G>A MYCBP2 p.Q2222* 0.10% 87.84% 43.76% 36.95% 2 2 2 0.004 0.003
13 100688137 A>T NALCN p.D468E 0.16% 18.60% 87.66% 1.65% 2 2.74 2.92 0.004 0.216
14 19285546 G>T OR4Q3 p.L40 0.22% 36.94% 40.31% 32.28% 2 2 2 0.313 0.107
16 66569387 T>G DPEP3 p.R262S 0.84% 45.61% 39.43% 76.59% 2 2.9 3.02 0.293 6.93e-4
16 82828230 C>A KCNG4 p.G121 0.04% 4.15% 26.82% 69.89% 2.43 3.09 3.49 0.083 0.259
17 7519157 insG TP53 p.Q167fs 4.61% 79.40% 62.62% 97.96% 2 2 2 0.085 0.003
17 32904736 C>T TADA2L p.R339W 0.12% 17.49% 59.92% 79.47% 2 2 2 0.002 0.002
19 12363315 G>A ZNF799 p.H299 0.17% 2.05% 26.23% 11.81% 2 2 3.06 0.062 0.618
19 16006577 insA ENSG00000167459 p.I38fs 4.82% 26.53% 48.47% 37.74% 2 2 3.06 0.286 0.809
20 5851563 G>A CHGB p.R258Q 0.14% 35.64% 45.50% 54.87% 2.57 2.86 3.64 0.057 0.005
21 45015744 G>A UBE2G2 p.I158 0.12% 21.57% 26.72% 20.89% 2 2 2 0.522 0.728
X 15731812 C>G ZRSR2 p.A95G 1.01% 64.01% 58.66% 72.08% 2.51 2.77 2.99 0.137 0.969
X 43893087 C>G EFHC2 e15-1 0.01% 9.88% 23.15% 7.35% 2 2.68 2.82 0.114 0.381
X 46318872 insA CHST7 p.T188fs 0.19% 3.67% 54.36% 38.84% 2 2.68 2.82 0.073 0.058
X 105040331 C>A NRK p.A681E 0.12% 4.08% 30.84% 52.45% 2 2 2 0.085 0.017
X 129374039 A>G RBMX2 p.K169E 0.30% 11.88% 38.36% 69.46% 2 2.65 2.77 0.002 0.003
*

Gene sets from Ensembl build 54 and Genbank (downloaded in May 2009) were used for annotation of mutations. T: primary tumor; M: metastasis; X: xenograft.